Publication
Transfection of pulmonary cells by stable pDNA-polycationic hybrid nanostructured particles
| dc.contributor.author | Gaspar, Diana P. | |
| dc.contributor.author | Vital, Joana | |
| dc.contributor.author | Leiva, María C. | |
| dc.contributor.author | Gonçalves, Lídia M. D. | |
| dc.contributor.author | Taboada, Pablo | |
| dc.contributor.author | Remuñán-López, Carmen | |
| dc.contributor.author | Vítor, Jorge M. B. | |
| dc.contributor.author | Almeida, António J. | |
| dc.date.accessioned | 2023-05-18T18:53:48Z | |
| dc.date.available | 2023-05-18T18:53:48Z | |
| dc.date.issued | 2019-02 | |
| dc.date.updated | 2022-10-19T21:20:56Z | |
| dc.description.abstract | Aim: Cationically modified solid lipid nanoparticles (SLN) were investigated as plasmid DNA (pDNA) carriers and transfection agents for the pulmonary route. Materials & methods:pDNA-loaded SLN were produced using glyceryl dibehenate or tristearate as matrix lipids and chitosan as surface charge modifier, and encapsulated by spray-drying in mannitol and trehalose microspheres. Results: Nanoparticles of 200 nm, and zeta potential around +15 mV were produced. Electrophorectic analysis confirmed plasmid stability and integrity. The pDNA-loaded SLN were able to transfect the Calu-3 and A549 pulmonary cell lines, while showing low cytotoxicity. Microencapsulation of SLN yielded dry powders suitable for inhalation that protected pDNA from degradation. Conclusion: Microencapsulated SLN are a promising safe and effective carrier system for pulmonary gene delivery following pulmonary administration. | pt_PT |
| dc.description.sponsorship | This work was supported by Fundação para a Ciência e Tecnologia, Portugal (projects UID/DTP/04138/2013 and PTDC/DTP-FTO/0094/2012, and grants SFRH/BD/89520/2012 and SFRH/BSAB/1210/2011). This work was also supported by Spanish Government (PN de I+D 2008-2011, ISCIII-Subdirección General de Evaluación y Fomento de la Investigación, Acción Estratégica de Salud, Projects FIS, PS09/00816, and MAT2013-40971-R), Xunta de Galicia (Project Competitive Reference Groups-FEDER Funds Ref. 2014/043 and Project Competitive Emergent Groups-FEDER Funds EM2013-046). Jorge Vitor's lab has been financed by New England Biolabs, Inc. (USA). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.2217/nnm-2018-0270 | pt_PT |
| dc.identifier.issn | 1743-5889 | |
| dc.identifier.issn | 1748-6963 | |
| dc.identifier.slug | cv-prod-314981 | |
| dc.identifier.uri | http://hdl.handle.net/10451/57469 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Future Medicine | pt_PT |
| dc.relation | PTDC/DTPFTO/ 0094/2012 | pt_PT |
| dc.relation | Research Institute for Medicines | |
| dc.relation | MICROENCAPSULATED LIPID NANOPARTICLES FOR PULMONARY DELIVERY OF BIOPHARMACEUTICAL AGENTS | |
| dc.relation | NEW SRATEGIES FOR ANTIGEN AND PROTEIN DELIVERY USING NANOBIOMATERIALS | |
| dc.relation.publisherversion | https://www.futuremedicine.com/doi/10.2217/nnm-2018-0270 | pt_PT |
| dc.subject | Chitosan | pt_PT |
| dc.subject | Gene delivery | pt_PT |
| dc.subject | Inhalation | pt_PT |
| dc.subject | Microencapsulation | pt_PT |
| dc.subject | Plasmid | pt_PT |
| dc.subject | Solid lipid nanoparticles | pt_PT |
| dc.subject | Spray-drying | pt_PT |
| dc.title | Transfection of pulmonary cells by stable pDNA-polycationic hybrid nanostructured particles | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | Research Institute for Medicines | |
| oaire.awardTitle | MICROENCAPSULATED LIPID NANOPARTICLES FOR PULMONARY DELIVERY OF BIOPHARMACEUTICAL AGENTS | |
| oaire.awardTitle | NEW SRATEGIES FOR ANTIGEN AND PROTEIN DELIVERY USING NANOBIOMATERIALS | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FDTP%2F04138%2F2013/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/OE/SFRH%2FBD%2F89520%2F2012/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/PIDDAC/SFRH%2FBSAB%2F1210%2F2011/PT | |
| oaire.citation.conferencePlace | Reino Unido | pt_PT |
| oaire.citation.endPage | 429 | pt_PT |
| oaire.citation.issue | 4 | pt_PT |
| oaire.citation.startPage | 407 | pt_PT |
| oaire.citation.title | Nanomedicine | pt_PT |
| oaire.citation.volume | 14 | pt_PT |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | OE | |
| oaire.fundingStream | PIDDAC | |
| person.familyName | Diogo Gonçalves | |
| person.familyName | Vítor | |
| person.familyName | Leitão das Neves Almeida | |
| person.givenName | Lídia Maria | |
| person.givenName | Jorge | |
| person.givenName | António José | |
| person.identifier | I-6590-2012 | |
| person.identifier.ciencia-id | 7211-22BA-86AD | |
| person.identifier.ciencia-id | FF19-99F4-3964 | |
| person.identifier.ciencia-id | 8312-F853-C47A | |
| person.identifier.orcid | 0000-0002-6799-2740 | |
| person.identifier.orcid | 0000-0001-6486-3444 | |
| person.identifier.orcid | 0000-0002-7807-4726 | |
| person.identifier.rid | M-3279-2013 | |
| person.identifier.scopus-author-id | 7801493621 | |
| person.identifier.scopus-author-id | 57195052432 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.cv.cienciaid | FF19-99F4-3964 | Jorge Manuel Barreto Vítor | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 3265148d-dc2d-4601-a832-2e72f7be5662 | |
| relation.isAuthorOfPublication | be15e90f-9cc9-4ad0-b9fd-465236b72e9a | |
| relation.isAuthorOfPublication | dab457ee-7a1d-4c3d-a906-1e8df92fffd6 | |
| relation.isAuthorOfPublication.latestForDiscovery | dab457ee-7a1d-4c3d-a906-1e8df92fffd6 | |
| relation.isProjectOfPublication | 9d71fb66-d168-40b8-9f2c-b0127783ea17 | |
| relation.isProjectOfPublication | d2e3b983-f8df-4c78-84f1-224fa56539f9 | |
| relation.isProjectOfPublication | 42a2988f-b282-4132-bd81-17ab51b266bd | |
| relation.isProjectOfPublication.latestForDiscovery | d2e3b983-f8df-4c78-84f1-224fa56539f9 |
